Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership78,428 shares
Latest Disclosed Value $ 15,658,150
D. E. Shaw & Co., Inc. ownership in LGND / Ligand Pharmaceuticals Incorporated

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 78,428 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $15,658,150 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 36,551 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of 114.57% during the quarter. The current value of the position is $18,383,523 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (LGND) in the form of stock options. The firm currently holds call options representing 6,600 of underlying shares valued at $1,317,690 USD and put options representing 2,200 of underlying shares valued at $439,230 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

LGND / Ligand Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 78,428 41,877 114.57 15,658 126.60 0.0069
2026-02-17 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 36,551 19,037 108.70 6,911 122.76 0.0038
2025-11-14 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 17,514 10,363 144.92 3,102 282.02 0.0018
2025-08-14 2025-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 7,151 7,151 813 0.0006
2024-11-14 2024-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -25,743 -100.00 0 -100.00
2024-08-14 2024-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 25,743 -36,849 -58.87 2,169 -52.59 0.0020
2024-05-15 2024-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 62,592 -25,317 -28.80 4,575 -27.13 0.0039
2024-02-14 2023-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 87,909 -17,812 -16.85 6,278 -0.88 0.0055
2023-11-14 2023-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 105,721 54,347 105.79 6,335 71.00 0.0066
2023-08-14 2023-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 51,374 2,037 4.13 3,704 2.07 0.0038
2023-05-15 2023-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 49,337 -1,964 -3.83 3,629 5.93 0.0039
2023-02-14 2022-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 51,301 51,301 3,427 0.0038
2021-08-16 2021-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -6,377 -100.00 0 -100.00
2021-05-17 2021-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 6,377 -26,913 -80.84 972 -70.64 0.0009
2021-02-16 2020-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 33,290 -44,291 -57.09 3,311 -55.23 0.0030
2020-11-16 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 77,581 -92,842 -54.48 7,395 -61.20 0.0076
2020-08-14 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 170,423 4,617 2.78 19,061 58.09 0.0227
2020-05-15 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 165,806 89,236 116.54 12,057 51.00 0.0188
2020-02-14 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 76,570 64,744 547.47 7,985 577.84 0.0091
2019-11-14 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 11,826 7,722 188.16 1,178 151.71 0.0015
2019-08-14 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,104 -12,101 -74.67 468 -77.03 0.0006
2019-05-15 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 16,205 -152,761 -90.41 2,037 -91.12 0.0026
2019-02-14 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 168,966 138,109 447.58 22,929 170.71 0.0316
2018-11-14 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 30,857 -49,557 -61.63 8,470 -49.16 0.0102
2018-08-14 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 80,414 24,909 44.88 16,659 81.73 0.0217
2018-05-15 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 55,505 -11,319 -16.94 9,167 0.19 0.0125
2018-02-14 2017-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 66,824 29,992 81.43 9,150 82.45 0.0126
2017-11-14 2017-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 36,832 36,832 5,015 0.0077
2017-05-15 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -2,579 -100.00 0 -100.00
2017-02-14 2016-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 2,579 2,579 0.00 262 0.0004
2016-11-14 2016-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -31,879 -100.00 0 -100.00
2016-08-15 2016-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 31,879 26,671 512.12 3,802 581.36 0.0070
2016-05-16 2016-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,208 -35,845 -87.31 558 -87.46 0.0010
2016-02-16 2015-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 41,053 41,053 0.00 4,451 0.0066
2015-11-16 2015-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -37,990 -100.00 0 -100.00
2015-08-14 2015-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 37,990 17,976 89.82 3,833 148.41 0.0057
2015-05-15 2015-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 20,014 20,014 0.00 1,543 0.0024
2014-11-14 2014-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -5,730 -100.00 0 -100.00
2014-08-14 2014-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,730 -8,681 -60.24 357 -52.90 0.0005
2014-02-14 2013-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 14,411 169 1.19 758 23.05 0.0010
2013-11-20 2013-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 14,242 6,146 75.91 616 103.30 0.0010
2013-11-14 2013-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 14,242 616
2013-08-14 2013-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 8,096 8,096 303 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 6,600 -13.16 1,318 -8.29 n/a n/a n/a
2026-02-17 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 7,600 375.00 1,437 407.42 n/a n/a n/a
2025-11-14 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 1,600 283 n/a n/a n/a
2021-11-15 2021-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F LIGAND PHARMACEUTICALS COM NEW Call 10,000 0.00 1,312 -13.97 n/a n/a n/a
2021-05-17 2021-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 10,000 1,525 n/a n/a n/a
2020-02-14 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 36,500 -35.40 3,633 -43.67 n/a n/a n/a
2019-08-14 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW Call 56,500 1,077.08 6,449 969.49 n/a n/a n/a
2019-05-15 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 4,800 -58.97 603 -62.03 n/a n/a n/a
2019-02-14 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 11,700 -60.20 1,588 -80.32 n/a n/a n/a
2018-11-14 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 29,400 66.10 8,070 120.07 n/a n/a n/a
2018-08-14 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW Call 17,700 77.00 3,667 121.97 n/a n/a n/a
2018-05-15 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 10,000 0.00 1,652 20.67 n/a n/a n/a
2018-02-14 2017-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 10,000 1,369 n/a n/a n/a
2017-05-15 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 10,000 1,016 n/a n/a n/a
2016-05-16 2016-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 6,200 0.00 672 26.55 n/a n/a n/a
2015-11-16 2015-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 6,200 531 n/a n/a n/a
2014-11-14 2014-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F LIGAND PHARMACEUTICALS COM NEW Call 10,000 -72.53 623 -74.55 n/a n/a n/a
2014-05-15 2014-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 36,400 550.00 2,448 729.83 n/a n/a n/a
2014-02-14 2013-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 5,600 -78.79 295 -74.19 n/a n/a n/a
2013-11-20 2013-09-30 13F/A LIGAND PHARMACEUTICALS COM NEW Call 26,400 -24.79 1,143 -12.95 n/a n/a n/a
2013-11-14 2013-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 26,400 1,143 n/a n/a n/a
2013-08-14 2013-06-30 13F LIGAND PHARMACEUTICALS COM NEW Call 35,100 1,313 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 2,200 439 n/a n/a n/a
2020-11-16 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 29,000 0.00 3,244 53.82 n/a n/a n/a
2020-05-15 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 29,000 2,109 n/a n/a n/a
2020-02-14 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 26,800 0.00 2,668 -12.78 n/a n/a n/a
2019-08-14 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 26,800 22.94 3,059 11.64 n/a n/a n/a
2019-05-15 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 21,800 21.79 2,740 12.80 n/a n/a n/a
2019-02-14 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW Put 17,900 3.47 2,429 -48.85 n/a n/a n/a
2018-11-14 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 17,300 8.12 4,749 43.26 n/a n/a n/a
2018-08-14 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 16,000 60.00 3,315 100.67 n/a n/a n/a
2018-05-15 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 10,000 1,652 n/a n/a n/a
2017-11-14 2017-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 2,800 0.00 340 14.86 n/a n/a n/a
2017-05-15 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 2,800 296 n/a n/a n/a
2014-11-14 2014-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 11,300 -72.03 704 -74.09 n/a n/a n/a
2014-05-15 2014-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 40,400 55.98 2,717 99.49 n/a n/a n/a
2014-02-14 2013-12-31 13F LIGAND PHARMACEUTICALS COM NEW Put 25,900 -58.69 1,362 -49.82 n/a n/a n/a
2013-11-20 2013-09-30 13F/A LIGAND PHARMACEUTICALS COM NEW Put 62,700 309.80 2,714 373.65 n/a n/a n/a
2013-11-14 2013-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 62,700 2,714 n/a n/a n/a
2013-08-14 2013-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 15,300 573 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.